Clinical iatrogenesis represents the most direct and visible form of harm caused by medical treatment itself. The term "iatrogenesis" derives from the Greek iatros (physician) and genesis (origin), meaning "the origin of illness in the person trying to cure it." Ivan Illich, in his 1975 work Medical Nemesis, developed the modern conceptual framework for iatrogenesis, distinguishing three interconnected levels: clinical, social, and cultural iatrogenesis.

Definition and Scope

Clinical iatrogenesis encompasses the direct physical harm produced by medical interventions. According to Hargadon, "the most careful recent work puts preventable medical error somewhere in the range of the third leading cause of death in the United States." This positions medical error as a leading cause of death, surpassing strokes and Alzheimer's disease. The harm manifests through hospital-acquired infections, surgical complications, adverse drug events, and complex medication interactions.

The Polypharmacy Problem

A particularly illustrative example of clinical iatrogenesis is what Hargadon describes as "the famous polypharmacy stack." This occurs when one medication is prescribed, a side effect appears, a second medication is prescribed for the side effect, and a third is prescribed for a side effect of the second. Eventually, patients find themselves "managing a portfolio of interactions no single prescriber fully tracks." The system becomes structured so that "no one is structurally responsible for the whole stack."

Systemic Rather Than Individual Failure

Hargadon emphasizes that clinical iatrogenesis does not result from individual malice or incompetence. Most physicians "are working inside a system whose incentives they did not design and often actively resent." The fundamental issue is structural: "an industry whose revenue scales with interventions will, over time, produce more interventions, and the point at which additional interventions begin producing net harm is not the point at which the industry notices." Hargadon attributes this pattern to what he terms the Law of Inevitable Exploitation (L.I.E.).

The GLP-1 Case Study

Hargadon presents GLP-1 medications as "the cleanest current example of the full pattern" of clinical iatrogenesis. The pattern unfolds in stages: first, food is "engineering[ed] past the body's natural stop signals" with "sugar, salt, and fat calibrated to override satiety." Rather than addressing the engineered food problem, the medical system introduces "a class of drugs that modify digestion, appetite, and reward, so the body stops pursuing the very products engineered to be irresistible."

The drugs deliver genuine short-term benefits

• people "have taken these drugs and felt better, sometimes much better." However, the long-term consequences include muscle loss, bone density loss, gastrointestinal and pancreatic effects whose "full shape is not yet known," and dependency where "stopping the drug tends to return the weight and sometimes more." Hargadon identifies this as particularly dangerous because "the drug does something"
• if it were ineffective, it would pose no risk. The danger lies precisely in its short-term effectiveness masking long-term costs.

The Generalized Pattern

This exemplifies a broader pattern that Hargadon argues characterizes clinical iatrogenesis: "Sell the problem. Sell the patch. Eventually, sell the fix for what the patch did. Each stage presents itself as medicine." The pattern sustains itself because each participant responds rationally to immediate incentives

• patients to real symptoms, physicians to presented conditions, and companies to market demands. "No one in the chain has to be a villain. The pattern produces itself."

Relationship to Social and Cultural Iatrogenesis

Clinical iatrogenesis operates as the foundation for Illich's other two categories. Social iatrogenesis occurs when "the category of 'things that require medical intervention' expands to encompass ordinary human experience." Normal childhood restlessness, grief, adolescent body dissatisfaction, and natural age-related changes become medicalized as disorders requiring treatment. This expansion creates more opportunities for clinical iatrogenesis by increasing the population receiving interventions.

Cultural iatrogenesis represents the deepest level, where inherited human frameworks for "making sense of pain, sickness, aging, grief, and death" are dissolved without replacement. The medical system "does not replace these frameworks with something better" but instead offers "a stream of interventions that promise to manage each dimension of the human condition separately."

Clinical Implications

Hargadon emphasizes that recognizing clinical iatrogenesis does not mean rejecting medical care entirely. "Some of the best interventions humans have ever invented live inside this system" including "antibiotics, vaccines, emergency surgery, insulin, and a long list of things that save lives every day." The goal is developing sufficient clarity to "tell when it is helping you and when it is selling you something," recognizing that medical providers are "mostly not in a position to make that distinction on your behalf, because the system is not structured to reward them for making it."

Clinical iatrogenesis thus represents not merely medical error, but a systemic feature of a medical industry whose financial incentives can diverge from patient wellbeing, producing harm through the very interventions designed to heal.